GE HealthCare Technologies (GEHC) Operating Income (2022 - 2026)
GE HealthCare Technologies (GEHC) posted Operating Income of $515.0 million for Q1 2026, down 37.73% on a QoQ basis from $827.0 million in Q4 2025, and down 18.12% year-over-year from $629.0 million in Q1 2025.
GE HealthCare Technologies (GEHC) Operating Income (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' Operating Income history runs 5 years deep, the most recent figure standing at $515.0 million for Q1 2026.
- Quarterly Operating Income fell 18.12% year-over-year to $515.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (down 2.39% YoY) and the FY2025 annual result came in at $2.8 billion, up 5.26% from the prior year.
- Operating Income was $515.0 million for Q1 2026 at GE HealthCare Technologies, down from $827.0 million in the prior quarter.
- Across five years, Operating Income topped out at $827.0 million in Q4 2025 and bottomed at $509.0 million in Q1 2022.
- A 5-year average of $638.8 million and a median of $629.0 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2025 — Operating Income advanced 16.48% — and 2026, when it fell 18.12%.
- GE HealthCare Technologies' Operating Income stood at $777.0 million in 2022, then slipped by 11.33% to $689.0 million in 2023, then grew by 16.26% to $801.0 million in 2024, then grew by 3.25% to $827.0 million in 2025, then sank by 37.73% to $515.0 million in 2026.
- Business Quant data shows GEHC's Operating Income at $515.0 million in Q1 2026, $827.0 million in Q4 2025, and $653.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 316.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 515.00 Mn |
| Dec 31, 2025 | 827.00 Mn |
| Sep 30, 2025 | 653.00 Mn |
| Jun 30, 2025 | 654.00 Mn |
| Mar 31, 2025 | 629.00 Mn |
| Dec 31, 2024 | 801.00 Mn |
| Sep 30, 2024 | 676.00 Mn |
| Jun 30, 2024 | 608.00 Mn |
| Mar 31, 2024 | 540.00 Mn |
| Dec 31, 2023 | 689.00 Mn |
| Sep 30, 2023 | 617.00 Mn |
| Jun 30, 2023 | 570.00 Mn |
| Mar 31, 2023 | 559.00 Mn |
| Dec 31, 2022 | 777.00 Mn |
| Sep 30, 2022 | 605.00 Mn |
| Jun 30, 2022 | 631.00 Mn |
| Mar 31, 2022 | 509.00 Mn |